Tetracore, Inc. of Rockville, MD at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair

Tetracore, Inc.

9901 Belward Campus Drive, Suite 300, 20850 Rockville, MD
United States of America

Telephone +1 240 268-5400
Fax +1 240 268-1107
sales@tetracore.com

This company is co-exhibitor of
Maryland Department of Commerce

Hall map

MEDICA 2017 hall map (Hall 16): stand C18

Fairground map

MEDICA 2017 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.02  DNA diagnosis kits

DNA diagnosis kits

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.07  Gene tests / molecular biological diagnostic

Gene tests / molecular biological diagnostic

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.07  Gene tests / molecular biological diagnostic
  • 03.01.07.02  DNA analysis
  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.07  Gene tests / molecular biological diagnostic
  • 03.01.07.03  DNA sequencing
  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.12  Units and systems for clinical chemical determination

Units and systems for clinical chemical determination

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.12  Units and systems for clinical chemical determination
  • 03.01.12.01  Blood sampling material and systems for clinical chemistry

Blood sampling material and systems for clinical chemistry

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.12  Units and systems for clinical chemical determination
  • 03.01.12.02  Diagnostic agents / kits for clinical chemistry

Diagnostic agents / kits for clinical chemistry

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.12  Units and systems for clinical chemical determination
  • 03.01.12.03  Semi-automatic units for clinical chemistry
  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.12  Units and systems for clinical chemical determination
  • 03.01.12.05  Reagents for clinical chemistry
  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry
  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry
  • 03.01.14.01  Point of care - testing systems
  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.15  Rapid tests - Immunochemistry
  • 03  Diagnostics
  • 03.02  Immunochemistry (Immunology)
  • 03.02.15  Rapid tests - Immunochemistry
  • 03.02.15.02  Infectious disease tests
  • 03  Diagnostics
  • 03.05  Infectious Immunology
  • 03.05.08  Rapid tests - Infectious immunology

Our products

Product category: Semi-automatic units for clinical chemistry, Reagents for clinical chemistry, Rapid tests - clinical chemistry, Point of care - testing systems, Rapid tests - Immunochemistry, Infectious disease tests, Rapid tests - Infectious immunology

Clinical Products RedLine Alert™

Intended Use: The Tetracore RedLine Alert™ Test is an immunochromatographic test intended for the rapid, in vitroqualitative presumptive identification of Bacillus anthracis from non-hemolytic Bacillus colonies cultured on sheep blood agar plates. The test is intended for use in clinical, public health, and hospital laboratories in conjunction with other markers and testing for the presumptive identification of Bacillus anthracis.

Easy to use and easy to interpret so you can accelerate the “can’t rule out” process.

On a non-hemolytic Bacillus , if the RedLine Alert™ Test is positive, then B. anthracis can’t be ruled out.  Submit the sample to the appropriate State Lab for confirmation.

RedLine Alert™ gives sentinel labs the ability to significantly shorten the time from when the plate is streaked until PCR confirmation is completed at the LRN reference lab.

Superior to gamma phage lysis when tested against 145 extremely well-characterized, independent, genetically and geographically diverse B. anthracis isolates, from 28 countries covering all major diversity groups: Ames-Sterne, Vollum, Western North America, Southern Africa, and Kruger.

RedLine Alert™ Test: 98.6% correct
Gamma Phage Lysis: 97.2% correct
The two false negative results with the RedLine Alert™ Test and the four false negative results with gamma phage lysis did not coincide, thus emphasizing that utilization of more than one detection method can aid in the identification of B. anthracis

No false positives (i.e. 100% correct negatives) test results with 49 non-hemolytic Bacillus spp, (other than B. anthracis).

More Less

Product category: Point of care - testing systems, Semi-automatic units for clinical chemistry

BioThreat Alert® Reader

BTA Reader CX

  • Cell phone reader capable of storing data on thousands of readings
  • Obtains results in ~60 seconds
  • Fully functional, ultra-portable Android-based cell phone
  • Wifi and Bluetooth connectivity
  • Handheld at 0.6 pounds (270 grams)
  • Dimensions 6.2"x2.8"x1.8" (16x7x5cm)
  • Includes rugged carrying case

More Less

Product category: DNA diagnosis kits, Gene tests / molecular biological diagnostic, DNA analysis, DNA sequencing, Units and systems for clinical chemical determination, Blood sampling material and systems for clinical chemistry, Diagnostic agents / kits for clinical chemistry, Semi-automatic units for clinical chemistry, Reagents for clinical chemistry, Rapid tests - clinical chemistry, Point of care - testing systems, Rapid tests - Immunochemistry, Infectious disease tests, Rapid tests - Infectious immunology

Antibody Products

  • Abrin
  • B. anthracis
  • B. globigii
  • Botulinum Toxins
  • Brucella
  • E. herbicola
  • F. tularensis
  • MS2
  • Ovalbumin
  • Ricin
  • Staphylococcal Enterotoxins
  • Y. pestis


NOTICE TO PURCHASER:

LIMITED LICENSE: The purchase price of this product includes limited and non-transferable rights to the purchaser to use only the purchased amount of product solely for in vitro, and internal, research and development activities. No right to use this product in any in vivo application, context, or activity is provided expressly or by implication to the purchaser. No right to use this product to conduct commercial services of any kind, including without limitation diagnostic services or conveying the results from the use of the product for a fee or other commercial consideration, is granted explicitly or by implication to the purchaser. Contact Tetracore Inc., 9901 Belward Campus Drive, Rockville, Maryland 20850, USA for information on the availability of other licenses, including those for commercial use of the product.

More Less

Product category: DNA diagnosis kits, Gene tests / molecular biological diagnostic, DNA analysis, DNA sequencing, Units and systems for clinical chemical determination, Blood sampling material and systems for clinical chemistry, Diagnostic agents / kits for clinical chemistry, Semi-automatic units for clinical chemistry, Reagents for clinical chemistry, Rapid tests - clinical chemistry, Point of care - testing systems, Rapid tests - Immunochemistry, Infectious disease tests, Rapid tests - Infectious immunology

ELISA Kits

For detection of select agents (and simulants) in environmental samples.
Not for diagnostic use of clinical samples.
 
  • Abrin
  • B. anthracis
  • B. globigii
  • Botulinum Toxins
  • Brucella
  • Burkholderia
  • F. tularensis
  • MS2 Bacteriaphage
  • Ricin
  • Staphylococcal Enterotoxins
  • Vibrio cholerae
  • Y. pestis


BioThreat Alert® ELISA Kits

The Plus/Minus (+/-) ELISA format utilizes a positive row of capture antibody above a negative row of normal, same species antibody.  The lower result can be subtracted from the top result to produce an adjusted result.  It is the preferred method for complex sample matrices. 

Custom ELISA production available

Multiple-plate formats available

More Less

About us

Company details

Providing Advanced Solutions to Your Molecular and Immunological Needs

Tetracore is a biotechnology research and development organization that develops highly innovative diagnostic reagents and assays for infectious diseases and biological warfare (BW) threat agents. The company focuses on antibody-based and nucleic acid-based detection reagents and technologies. Tetracore offers a broad range of highly-specific, rapid, antibody-based test kits and antibody reagents for the detection of BW infectious agents and toxins, including the first FDA cleared test kit for identification of B. anthracis from colonies. Tetracore also offers a product line of real-time, probe hydrolysis Polymerase Chain Reaction (PCR) test kits for sensitive and specific detection of animal pathogens. In addition, Tetracore contracts with the US Government for development of: real-time PCR diagnostic tests for BW agents, novel nucleic acid extraction procedures, and specialized nucleic acid products.

The four founding scientists, Gary Long, Ph. D., Beverly L. Mangold, Ph.D.*, Thomas W. O'Brien, Ph.D., and William M. Nelson, M.D. (CDR, US Navy Ret.), have been leaders in the development of state-of-the-art diagnostic technology for use by the Joint Program Office for Bio-defense (JPO), the Department of Defense (DOD), FBI, and DOE. These scientists bring their extensive expertise and skills to Tetracore Inc. in order to provide these same organizations with an expanded production capability, greater flexibility in the development of new technology, and the ability to innovate in an entrepreneurial atmosphere

Tetracore's strong scientific team and powerful technology base positions the company at the forefront in the development and production of today's important detection tools for Clinical, Veterinary, and Domestic Preparedness Testing.

More Less